VASOLAN Side Effects

6192287-2 | Oculomucocutaneous Syndrome
on May 12, 2009 Female patient from JAPAN , 83 years of age, was diagnosed with atrial flutter, arrhythmia (What is arrhythmia?), angina pectoris, cardiac failure chronic, depression (What is depression?), anxiety disorder, constipation (What is constipation?) and was treated with Vasolan (View Usage). Patient experienced the following unwanted or unexpected effects: oculomucocutaneous syndrome. Vasolan dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MAPROTILINE HYDROCHLORIDE (View Maprotiline Hydrochloride Review and Maprotiline Hydrochloride Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), KEISHIBUKURYOUGAN (View Keishibukuryougan Review and Keishibukuryougan Label ), PURSENNID (View Pursennid Review and Pursennid Label ). Patient was hospitalized.

5305332-0 | Eye Infection, Stevens-johnson Syndrome, Stomach Discomfort
Patient was taking Vasolan (View Usage). Patient had the following side effects: eye infection (What is eye infection?), stevens-johnson syndrome, stomach discomfort on Apr 03, 2007 from JAPAN Additional patient health information: Female patient , 71 years of age, was diagnosed with arrhythmia (What is arrhythmia?) and. Vasolan dosage: Df Po. During the same period patient was treated with LIPOVAS (View Lipovas Review and Lipovas Label ), BENET (View Benet Review and Benet Label ), ONEALFA (View Onealfa Review and Onealfa Label ). Patient was hospitalized.

5304404-4 | Aggression, Agitation, Aspartate Aminotransferase Increased, Atrial Fibrillation, Blood Alkaline Phosphatase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Decreased, Blood Urine Present
Adverse event was reported on Apr 04, 2007 by a Male patient taking Vasolan (View Usage) (Dosage: 10 Mg Once Iv) was diagnosed with atrial fibrillation (What is atrial fibrillation?), tachycardia, restlessness and. Location: JAPAN , 79 years of age, After Vasolan was administered, patient had the following side effects: aggression, agitation, aspartate aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood pressure decreased, blood urine present. During the same period patient was treated with DORMICUM (20 Mg Con Iv) (View Dormicum Review and Dormicum Label ), HYDROXYZINE HYDROCHLORIDE (View Hydroxyzine Hydrochloride Review and Hydroxyzine Hydrochloride Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ).

5291390-9 | International Normalised Ratio Increased, Nausea, Overdose, Renal Impairment, Therapeutic Agent Toxicity
on Mar 19, 2007 Female patient from JAPAN , 83 years of age, was treated with Vasolan (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased, nausea (What is nausea?), overdose, renal impairment, therapeutic agent toxicity. Vasolan dosage: Df Po. During the same period patient was treated with WARFARIN SODIUM (Df Po) (View Warfarin Sodium Review and Warfarin Sodium Label ), DIGOXIN (Df) (View Digoxin Review and Digoxin Label ), BUCOLOME (Df Po) (View Bucolome Review and Bucolome Label ). Patient was hospitalized.


5261426-X | International Normalised Ratio Increased, Nausea, Overdose, Renal Impairment, Therapeutic Agent Toxicity, Urinary Tract Disorder
on Feb 23, 2007 Female patient from JAPAN , 83 years of age, was treated with Vasolan (View Usage). Patient had the following side effects: international normalised ratio increased, nausea (What is nausea?), overdose, renal impairment, therapeutic agent toxicity, urinary tract disorder. Vasolan dosage: Df Po. During the same period patient was treated with WARFARIN SODIUM (Df Po) (View Warfarin Sodium Review and Warfarin Sodium Label ), DIGOXIN (Df) (View Digoxin Review and Digoxin Label ), BUCOLOME (Df Po) (View Bucolome Review and Bucolome Label ). Patient was hospitalized.

5237037-9 | Abnormal Behaviour, Cardio-respiratory Arrest, Cardiovascular Insufficiency, Convulsion, Dysarthria, Pulmonary Oedema
Patient was taking Vasolan (View Usage). After Vasolan was administered, patient had the following side effects: abnormal behaviour, cardio-respiratory arrest, cardiovascular insufficiency, convulsion, dysarthria, pulmonary oedema on Jan 29, 2007 from JAPAN Additional patient health information: Male patient , 30 years of age, was diagnosed with ventricular arrhythmia and. Vasolan dosage: 407 Tab Once Po.

5223176-5 | Abnormal Behaviour, Cardio-respiratory Arrest, Cardiovascular Insufficiency, Convulsion, Pulmonary Oedema
Adverse event was reported on Jan 12, 2007 by a Male patient taking Vasolan (View Usage) (Dosage: 407 Tab Once Po) was diagnosed with ventricular arrhythmia and. Location: JAPAN , 30 years of age, Patient experienced the following unwanted or unexpected effects: abnormal behaviour, cardio-respiratory arrest, cardiovascular insufficiency, convulsion, pulmonary oedema.

5207306-7 | Atrial Fibrillation, Cardio-respiratory Arrest
on Dec 25, 2006 Male patient from JAPAN , 79 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), restlessness and was treated with Vasolan (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardio-respiratory arrest. Vasolan dosage: Df Iv. During the same period patient was treated with MIDAZOLAM HCL (Df Iv) (View Midazolam Hcl Review and Midazolam Hcl Label ).

4654985-9 | Heart Rate Decreased, Respiratory Arrest
on Apr 20, 2005 Male patient from , 80 years of age, was treated with Vasolan (View Usage). After Vasolan was administered, patient had the following side effects: heart rate decreased, respiratory arrest. Vasolan dosage: 15 Mg Iv.

4648696-3 | Blood Potassium Increased, Bradycardia, Malaise
Patient was taking Vasolan (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased, bradycardia, malaise on Mar 31, 2005 from Additional patient health information: Male patient , 79 years of age, . Vasolan dosage: 80 Mg Day Po. During the same period patient was treated with CLEAMINE (View Cleamine Review and Cleamine Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ), LASIX (View Lasix Review and Lasix Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.

4617092-7 | Rhabdomyolysis
Adverse event was reported on Jan 14, 2005 by a Male patient taking Vasolan (View Usage) (Dosage: ) was diagnosed with prophylaxis, stress (What is stress?), sedation, intubation and. Location: , 79 years of age, Patient had the following side effects: rhabdomyolysis. During the same period patient was treated with HORIZON (View Horizon Review and Horizon Label ), PREDONINE (View Predonine Review and Predonine Label ), PEPCID (View Pepcid Review and Pepcid Label ), DORMICUM (MIDAZOLAM) (View Dormicum (midazolam) Review and Dormicum (midazolam) Label ), METHYLPREDNISOLONE SODIUM SUCCINATE (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), CARBENIN (View Carbenin Review and Carbenin Label ).